TriangleNCT04541355 · OUTCOME
Frequency of Hearing Handicap
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- Up to 18 weeks
What was measured
The Hearing Handicap Inventory for Adults -Screener (HHIA-S), is a 10-item, self-assessment screening assessment developed to quickly determine the suggested level of hearing handicap. The participants respond to each of the items with a Yes (score of 4), Sometimes (score of 2), or No (score of 0). Total Scores are then summed for overall score (range 0-40) and then assigned a category for a suggested hearing handicap; 0-8 suggesting no handicap, 10-24 suggesting a mild-moderate handicap, and 26-40 suggesting significant hearing handicap. The frequency of participants for worse reported score will be reported
Groups in this outcome
Cisplatin, Radiotherapy, STS
Participants undergo standard of care radiation therapy daily in combination with cisplatin on day 1. Between 4-5 hours after each cisplatin infusion, patients also receive sodium thiosulfate over 1-2 hours on day 1. Treatment will continue on either a 1 week or 3 week cycle per physician discretion for up to 6-7 weeks in the absence of disease progression or unacceptable toxicity.
| Group | Source count |
|---|---|
| Cisplatin, Radiotherapy, STS | 16 |
Reported measurements
Suggesting no handicap
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Cisplatin, Radiotherapy, STS | 11 | Not reported | Not reported | Not reported | Not reported |
Suggesting a mild-moderate handicap
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Cisplatin, Radiotherapy, STS | 5 | Not reported | Not reported | Not reported | Not reported |
Suggesting significant hearing handicap
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Cisplatin, Radiotherapy, STS | 0 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 11
- title
- Suggesting no handicap
- categories
- measurements
- group Id
- OG000
- value
- 5
- title
- Suggesting a mild-moderate handicap
- categories
- measurements
- group Id
- OG000
- value
- 0
- title
- Suggesting significant hearing handicap
- denoms
- counts
- group Id
- OG000
- value
- 16
- units
- Participants
- description
- The Hearing Handicap Inventory for Adults -Screener (HHIA-S), is a 10-item, self-assessment screening assessment developed to quickly determine the suggested level of hearing handicap. The participants respond to each of the items with a Yes (score of 4), Sometimes (score of 2), or No (score of 0). Total Scores are then summed for overall score (range 0-40) and then assigned a category for a suggested hearing handicap; 0-8 suggesting no handicap, 10-24 suggesting a mild-moderate handicap, and 26-40 suggesting significant hearing handicap. The frequency of participants for worse reported score will be reported
- groups
- description
- Participants undergo standard of care radiation therapy daily in combination with cisplatin on day 1. Between 4-5 hours after each cisplatin infusion, patients also receive sodium thiosulfate over 1-2 hours on day 1. Treatment will continue on either a 1 week or 3 week cycle per physician discretion for up to 6-7 weeks in the absence of disease progression or unacceptable toxicity.
- id
- OG000
- title
- Cisplatin, Radiotherapy, STS
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- Up to 18 weeks
- title
- Frequency of Hearing Handicap
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice